ENANTA PHARMACEUTICALS, INC
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | $11.3M | $281.3M | $16.6M |
| FY2017 | $25.0M | $326.6M | $65.7M |
| FY2018 | $20.5M | $414.2M | $63.9M |
| FY2019 | $27.3M | $489.8M | $51.2M |
| FY2020 | $30.6M | $486.1M | $87.1M |
| FY2021 | $39.4M | $438.8M | $57.2M |
| FY2022 | $54.1M | $375.4M | $44.0M |
| FY2023 | $245.5M | $462.3M | $85.4M |
| FY2024 | $247.8M | $376.7M | $37.2M |
| FY2025 | $216.0M | $280.7M | $32.3M |